Accessibility Menu
Milestone Scientific logo

Milestone Scientific(NYSEMKT) MLSS

Market Cap$44.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)-96%
5 Year-73%
1 Year-17%
1 Month+34%
$0.48
-5.02%
-0.03Today
Milestone Scientific last closing stock price
MetricPriceDate
Last closeUSD 0.502026-08-28
Milestone Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.41%USD 0.482026-08-21
1 month+33.51%USD 0.382026-07-29
3 month+29.72%USD 0.392026-05-29
Year to date+83.88%USD 0.272025-12-31
1 year-16.64%USD 0.602025-08-28
3 year-52.03%USD 1.052023-08-29
5 year-72.86%USD 1.852021-08-27
Since inception-96.48%USD 14.251995-11-03

Milestone Scientific Financials at a Glance

Market Cap

$44.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$9.42M

Net Income (TTM)

-$4.14M

EPS (TTM)

-$0.05

P/E Ratio

-10.29

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Price

$0.48

Volume

27,563

Open

$0.49

Previous Close

$0.48

Daily Range

$0.48 - $0.49

52-Week Range

$0.22 - $0.65

Estimated Earnings Date

Nov 12, 2026

MLSS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Milestone Scientific

Milestone Scientific makes computer-controlled injection devices for dentists and doctors. Its products help deliver anesthesia more precisely and comfortably. These tools aim to improve patient experience and safety during common medical and dental procedures.

Needles, But Smarter: What Milestone Sells

  • Dental Injection Systems (98% of revenue): Devices like CompuDent and STA deliver local anesthesia for dental procedures, targeting dentists and dental clinics.
  • Medical Injection Systems (2% of revenue): CompuFlo and CompuMed provide controlled drug delivery for medical fields such as surgery, dermatology, and orthopedics.
  • Disposable Handpieces: Single-use attachments for injection systems, designed for hygiene and tactile control, used by both dental and medical professionals.
  • Digital Data Recording: Devices track and record injection details, supporting clinical documentation and compliance for healthcare providers.

Growth Spurts and Global Footprints

  • Entered China dental market in 2025, generating $310,000 in sales that year.
  • Expanded CompuFlo Epidural system globally after FDA clearances in 2017 and 2023.
  • Launched e-commerce platform, which made up 49% of sales in 2025.
  • Secured exclusive and non-exclusive distribution deals in 37 countries by 2025.
  • Raised $800,000 in convertible notes from directors in April 2025 to support operations.

Why Milestone Is a Bit Different

Milestone’s Dynamic Pressure Sensing technology gives real-time feedback during injections, aiming for safer and more precise drug delivery. Its products are used in over 95 million dental injections worldwide since 2007. The company relies on a mix of direct sales, e-commerce, and international distributors for global reach.

Five Things You Need to Know

  • Net sales were $8,973,982 in 2025, up 4% from 2024.
  • Dental segment made up 98% of 2025 revenue; medical was 2% but grew 75% year-over-year.
  • International sales were 45% of total in 2025, with products in 37 countries.
  • Gross margin fell to 71% in 2025, down from 75% in 2024.
  • Net loss was $5.7 million in 2025, compared to $4.7 million in 2024.

Bottom Line

Milestone has focused on computer-controlled injection systems for dental and medical use, expanding globally and online. The company faces ongoing losses but continues to adapt its business and product mix.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

15

CEO

Eric C Hines, MBA

Website

www.milestonescientific.com

Headquarters

Roseland, NJ 07068, US

MLSS Financials

Key Financial Metrics (TTM)

Gross Margin

69.61%

Operating Margin

-43.56%

Net Income Margin

-43.98%

Return on Equity

-149.08%

Return on Capital

-148.63%

Return on Assets

-49.64%

Earnings Yield

-9.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

88.74M

Volume

27.56K

Avg. Volume

174.32K

Financials (TTM)

Gross Profit

$6.56M

Operating Income

-$4.10M

EBITDA

-$3.95M

Operating Cash Flow

-$642.64K

Capital Expenditure

$5.00

Free Cash Flow

-$642.63K

Cash & ST Invst.

$2.07M

Total Debt

$615.70K

Milestone Scientific Performance Analysis

Milestone Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 8,805,906-14.5%
20232023-12-31USD 9,827,44411.6%
20242024-12-31USD 8,629,928-12.2%
20252025-12-31USD 8,973,9824.0%
Milestone Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.6%
Q42025-12-31-12.8%
Q12026-03-315.1%
Q22026-06-3031.4%
Milestone Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.1224.4%
20232023-12-31USD -0.10-22.8%
20242024-12-31USD -0.06-37.9%
20252025-12-31USD -0.0717.9%
Milestone Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.7%
Q42025-12-313.6%
Q12026-03-3124.4%
Q22026-06-302.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.84M

+22.3%

Gross Profit

$1.91M

+18.1%

Gross Margin

67.23%

N/A

Market Cap

$44.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.97M

N/A

Employees

15

N/A

Net Income

-$1.06M

+28.6%

EBITDA

-$1.04M

+27.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$2.07M

+62.2%

Total Debt

$615.70K

-43.3%

Accounts Receivable

$1.05M

+52.5%

Inventory

$3.09M

-20.8%

Long Term Debt

$479.65K

-49.1%

Short Term Debt

$136.05K

-5.3%

Return on Assets

-49.64%

N/A

Return on Invested Capital

-1.04%

N/A

Free Cash Flow

-$589.27K

+66.7%

Operating Cash Flow

-$585.13K

+66.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
POCIPrecision Optics Corporation, Inc.
$4.30-2.27%
HBIOHarvard Bioscience, Inc.
$8.11+2.27%
NTRBNutriband Inc.
$4.37-2.09%
MIRAMIRA Pharmaceuticals, Inc.
$0.77+2.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About MLSS

What is the current price of Milestone Scientific?

Milestone Scientific is trading at $0.48 per share.

What is the 52-week range for Milestone Scientific?

Over the past 52 weeks, Milestone Scientific has traded between $0.22 and $0.65.

How much debt does Milestone Scientific have?

As of the most recent reporting period, Milestone Scientific reported total debt of $615.70K.

How much cash does Milestone Scientific have on hand?

Milestone Scientific reported $2.07M in cash and cash equivalents in its most recent financial results.

What is Milestone Scientific’s dividend yield?

Milestone Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services